Abstract:Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA BACKGROUND & AIMS: Hepatocyte nuclear factor 4α (HNF4α) is a liver enriched transcription factor and is indispensable for liver development. However, the role of HNF4α in hepatocellular carcinoma (HCC) metastasis remains largely unknown. METHODS: 429 HCC tissues were involved in the correlation analysis of HNF4α levels with tumor features and patient outcomes. Effect of HNF4α on HCC metastasis was monitored through in vivo imaging system. Expression of HNF4α, RelA(p65) or microRNAs in human HCCs was determined by Real-time PCR, western blot or immunohistochemistry. Point mutation and ChIP assay were performed to detect the interaction of HNF4α with the promoter of target microRNA. 3’UTR reporter assay was conducted to determine the regulation of RelA by microRNAs. RESULTS: Reduced HNF4α expression correlated well with the aggressive clinicopathological characteristics of HCC and predicted poor prognosis of patients. HNF4α levels were even lower in metastatic HCCs, and ectopic HNF4α expression suppressed the metastasis of hepatoma cells both in vitro and in vivo. HNF4α suppressed HCC metastasis through inhibiting RelA expression and NFκB activity. miR-7 and miR-124, which were transcriptionally up-regulated by HNF4α, repressed RelA expression via interaction with RelA-3’UTR. Herein, HNF4α suppresses NF-κB activity and RelA expression via a miR-7 and miR-124-dependent manner. Moreover, combination of HNF4α and NF-κB exhibited more powerful predictive efficiency of patient prognosis. CONCLUSIONS: Considering the importance of HNF4α and NF-κB in chronic liver disease, the suppression of NF-κB by HNF4α is not only essential in connecting hepatic inflammation and tumorigenesis, but also indicates novel strategy in HCC prevention and therapy. Citation Format: Bei-Fang Ning, Jiao Liu, Wen-Ping Xu, Chuan Yin, Xin Zhang, Wei-Fen Xie. HNF4α inhibits liver cancer metastasis via suppression of NF-кB activity. [abstract]. In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr 134. doi:10.1158/1538-7445.AM2014-134

NF-κB Signaling Relieves Negative Regulation by Mir-194 in Hepatocellular Carcinoma by Suppressing the Transcription Factor HNF-1α.

Genome-wide Screening Reveals That Mir-195 Targets the TNF-α/NF-κB Pathway by Down-Regulating IκB Kinase Alpha and TAB3 in Hepatocellular Carcinoma.

Hepatocyte Nuclear Factor-4Α Reverses Malignancy of Hepatocellular Carcinoma Through Regulating Mir-134 in the DLK1-DIO3 Region.

Mir-194 is A Marker of Hepatic Epithelial Cells and Suppresses Metastasis of Liver Cancer Cells in Mice

MicroRNA-145 Suppresses Hepatocellular Carcinoma by Targeting IRS1 and Its Downstream Akt Signaling.

Mir-124 Inhibits Progression of Hepatocarcinoma by Targeting KLF4 and Promises a Novel Diagnostic Marker

Abstract 134: HNF4α Inhibits Liver Cancer Metastasis Via Suppression of NF-кB Activity

Temporal regulation of HIF-1 and NF-κB in hypoxic hepatocarcinoma cells.

Mir‐30c‐1* Promotes Natural Killer Cell Cytotoxicity Against Human Hepatoma Cells by Targeting the Transcription Factor HMBOX1

Mir-1204 Promotes Hepatocellular Carcinoma Progression Through Activating MAPK and C-Jun/ap1 Signaling by Targeting ZNF418

Hepatocyte Nuclear Factor 4 Alpha-Nuclear Factor-Kappa B Feedback Circuit Modulates Liver Cancer Progression

Long Noncoding RNA Mir503hg, a Prognostic Indicator, Inhibits Tumor Metastasis by Regulating the HNRNPA2B1/NF-κB Pathway in Hepatocellular Carcinoma.

Perturbation of MicroRNA-370/Lin-28 homolog A/nuclear factor kappa B regulatory circuit contributes to the development of hepatocellular carcinoma.

Mir-296-5p Suppresses EMT of Hepatocellular Carcinoma Via Attenuating NRG1/ERBB2/ERBB3 Signaling

DNMT1-induced miR-378a-3p silencing promotes angiogenesis via the NF-κB signaling pathway by targeting TRAF1 in hepatocellular carcinoma

MicroRNA‐127‐5p Targets the Biliverdin Reductase B/nuclear Factor‐κb Pathway to Suppress Cell Growth in Hepatocellular Carcinoma Cells

Mir-139 Regulates the Proliferation and Invasion of Hepatocellular Carcinoma Through the WNT/TCF-4 Pathway.

Mir-1188 at the Imprinted Dlk1-Dio3 Domain Acts As A Tumor Suppressor in Hepatoma Cells

NF-kappaB P50/P65 Hetero-Dimer Mediates Differential Regulation of CD166/ALCAM Expression Via Interaction with Micorna-9 after Serum Deprivation, Providing Evidence for a Novel Negative Auto-Regulatory Loop

Down-regulation of MAP2K1 by Mir-539 Inhibits Hepatocarcinoma Progression.

NR4A1 Mediates NK‐cell Dysfunction in Hepatocellular Carcinoma Via the IFN‐γ/p‐STAT1/IRF1 Pathway